Source:http://linkedlifedata.com/resource/pubmed/id/11283812
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2001-4-3
|
pubmed:abstractText |
We conducted a multicenter case-control study to identify risk factors for histoplasmosis among persons with acquired immunodeficiency syndrome (AIDS) and to evaluate predictors of a poor outcome (defined as death or admission to the intensive care unit). Patients with histoplasmosis were each matched by age, sex, and CD4 lymphocyte count to 3 controls. From 1996 through 1999, 92 case patients and 252 controls were enrolled. Of the case patients, 81 (89%) were men, 50 (55%) were black, 78 (85%) had a CD4 lymphocyte count of <100 cells/microL, 80 (87%) were hospitalized, and 11 (12%) died. Multivariable analysis found that receipt of antiretroviral therapy and of triazole drugs were independently associated with a decreased risk of histoplasmosis. Chronic medical conditions and a history of infections with herpes simplex virus were associated with poor outcome. Triazoles should be considered for chemoprophylaxis for persons with AIDS, especially those who take part in high-risk activities that involve frequent exposure to soil, who have CD4 lymphocyte counts of <100 cells/microL, and who live in areas where histoplasmosis is endemic.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1058-4838
|
pubmed:author |
pubmed-author:BambergerD MDM,
pubmed-author:CloudGG,
pubmed-author:HajjehR ARA,
pubmed-author:HendersonHH,
pubmed-author:HollowayMM,
pubmed-author:KauffmanC ACA,
pubmed-author:LancasterDD,
pubmed-author:National Institute of Allergy and Infectious Diseases Mycoses Study Group,
pubmed-author:PappasP GPG,
pubmed-author:PhelanM AMA,
pubmed-author:SkahanK JKJ,
pubmed-author:WheatL JLJ
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1215-20
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:11283812-AIDS-Related Opportunistic Infections,
pubmed-meshheading:11283812-Adult,
pubmed-meshheading:11283812-Aged,
pubmed-meshheading:11283812-Animals,
pubmed-meshheading:11283812-Case-Control Studies,
pubmed-meshheading:11283812-Female,
pubmed-meshheading:11283812-Histoplasmosis,
pubmed-meshheading:11283812-Humans,
pubmed-meshheading:11283812-Male,
pubmed-meshheading:11283812-Middle Aged,
pubmed-meshheading:11283812-Predictive Value of Tests,
pubmed-meshheading:11283812-Risk Factors,
pubmed-meshheading:11283812-Treatment Outcome
|
pubmed:year |
2001
|
pubmed:articleTitle |
Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.
|
pubmed:affiliation |
Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. rfh5@cdc.gov
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study
|